• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童骨转换标志物:从实验室挑战到临床解读。

Bone Turnover Markers in Children: From Laboratory Challenges to Clinical Interpretation.

机构信息

Clinical Chemistry Department, CHU de Liège, Liège, Belgium.

Shriners Hospital for Children, McGill University, Montreal, Canada.

出版信息

Calcif Tissue Int. 2023 Feb;112(2):218-232. doi: 10.1007/s00223-022-00964-2. Epub 2022 Mar 4.

DOI:10.1007/s00223-022-00964-2
PMID:35243530
Abstract

Bone turnover markers (BTMs) have been developed many years ago to study, in combination with imaging techniques, bone remodeling in adults. In children and adolescents, bone metabolism differs from adults since it implies both growth and bone remodeling, suggesting an age- and gender-dependent BTM concentration. Therefore, specific studies have evaluated BTMs in not only physiological but also pathological conditions. However, in pediatrics, the use of BTMs in clinical practice is still limited due to these many children-related specificities. This review will discuss about physiological levels of BTMs as well as their modifications under pathological conditions in children and adolescents. A focus is also given on analytical and clinical challenges that restrain BTM usefulness in pediatrics.

摘要

骨转换标志物(BTMs)多年前被开发出来,用于结合影像学技术研究成年人的骨重塑。在儿童和青少年中,骨代谢与成年人不同,因为它既包括生长又包括骨重塑,提示 BTM 浓度与年龄和性别有关。因此,不仅在生理条件下,而且在病理条件下,都有专门的研究来评估 BTMs。然而,在儿科领域,由于涉及到许多儿童特有的因素,BTMs 的临床应用仍然有限。这篇综述将讨论 BTMs 的生理水平以及在儿童和青少年病理条件下的变化。此外,还重点讨论了限制 BTMs 在儿科应用的分析和临床挑战。

相似文献

1
Bone Turnover Markers in Children: From Laboratory Challenges to Clinical Interpretation.儿童骨转换标志物:从实验室挑战到临床解读。
Calcif Tissue Int. 2023 Feb;112(2):218-232. doi: 10.1007/s00223-022-00964-2. Epub 2022 Mar 4.
2
Broad application prospects of bone turnover markers in pediatrics.骨转换标志物在儿科领域的广泛应用前景。
J Clin Lab Anal. 2022 Sep;36(9):e24656. doi: 10.1002/jcla.24656. Epub 2022 Aug 10.
3
Decreased markers of bone turnover in children and adolescents with type 1 diabetes.1 型糖尿病患儿和青少年骨转换标志物降低。
Pediatr Diabetes. 2020 May;21(3):505-514. doi: 10.1111/pedi.12987. Epub 2020 Feb 3.
4
[Use of CTX-I and PINP as bone turnover markers: National Bone Health Alliance recommendations to standardize sample handling and patient preparation to reduce pre-analytical variability].[使用CTX-I和PINP作为骨转换标志物:国家骨健康联盟关于规范样本处理和患者准备以减少分析前变异性的建议]
Ann Biol Clin (Paris). 2018 Aug 1;76(4):373-391. doi: 10.1684/abc.2018.1363.
5
Use of CTX-I and PINP as bone turnover markers: National Bone Health Alliance recommendations to standardize sample handling and patient preparation to reduce pre-analytical variability.CTX-I 和 PINP 作为骨转换标志物的应用:国家骨健康联盟建议规范样本处理和患者准备,以减少分析前的变异性。
Osteoporos Int. 2017 Sep;28(9):2541-2556. doi: 10.1007/s00198-017-4082-4. Epub 2017 Jun 19.
6
Reference intervals in Danish children and adolescents for bone turnover markers carboxy-terminal cross-linked telopeptide of type I collagen (β-CTX), pro-collagen type I N-terminal propeptide (PINP), osteocalcin (OC) and bone-specific alkaline phosphatase (bone ALP).丹麦儿童和青少年的骨转换标志物Ⅰ型胶原羧基端交联肽(β-CTX)、Ⅰ型前胶原氨基端前肽(PINP)、骨钙素(OC)和骨碱性磷酸酶(骨 ALP)的参考区间。
Bone. 2021 May;146:115879. doi: 10.1016/j.bone.2021.115879. Epub 2021 Feb 7.
7
Biochemical bone turnover markers in hormonal disorders in adults: a narrative review.成人激素紊乱中的生化骨转换标志物:叙述性综述。
J Endocrinol Invest. 2020 Oct;43(10):1409-1427. doi: 10.1007/s40618-020-01269-7. Epub 2020 Apr 25.
8
Reference intervals for serum concentrations of three bone turnover markers for men and women.男性和女性三种骨转换标志物血清浓度参考区间。
Bone. 2013 Dec;57(2):399-404. doi: 10.1016/j.bone.2013.09.010. Epub 2013 Sep 27.
9
Effects of denosumab on bone turnover markers in postmenopausal osteoporosis.地舒单抗对绝经后骨质疏松症患者骨转换标志物的影响。
J Bone Miner Res. 2011 Mar;26(3):530-7. doi: 10.1002/jbmr.251.
10
Contribution of bone turnover markers to the variation in bone mineral density: a study in Vietnamese men and women.骨转换标志物对骨密度变化的贡献:越南男女的研究。
Osteoporos Int. 2018 Dec;29(12):2739-2744. doi: 10.1007/s00198-018-4700-9. Epub 2018 Sep 8.

引用本文的文献

1
A novel splice-altering frameshift variant in the COL1A1 gene underlies osteogenesis imperfecta type I: molecular characterization of a four-generation Chinese pedigree and literature review.COL1A1基因中一种新的剪接改变移码变异是I型成骨不全的基础:一个四代中国家系的分子特征及文献综述
Hum Genomics. 2025 Aug 31;19(1):103. doi: 10.1186/s40246-025-00816-8.
2
Bone Health in Children and Adolescents with Type 1 Diabetes: Optimizing Bone Accrual and Preventing Fractures.1型糖尿病儿童和青少年的骨骼健康:优化骨质积累与预防骨折
Nutrients. 2025 Jul 23;17(15):2400. doi: 10.3390/nu17152400.
3
Pathways linking sports participation to bone density and geometry among adolescents: ABCD growth study.
青少年中体育活动与骨密度和骨几何形态之间的关联途径:ABCD生长研究
Arch Osteoporos. 2025 May 7;20(1):60. doi: 10.1007/s11657-025-01550-3.
4
Update on the role of bone turnover markers in the diagnosis and management of osteoporosis: a consensus paper from The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), International Osteoporosis Foundation (IOF), and International Federation of Clinical Chemistry and Laboratory Medicine (IFCC).骨转换标志物在骨质疏松症诊断和管理中的作用更新:来自欧洲骨质疏松症、骨关节炎和肌肉骨骼疾病临床与经济学会(ESCEO)、国际骨质疏松症基金会(IOF)以及国际临床化学和检验医学联合会(IFCC)的共识文件。
Osteoporos Int. 2025 Apr;36(4):579-608. doi: 10.1007/s00198-025-07422-3. Epub 2025 Mar 28.
5
Reference Intervals (RIs) of the Bone Turnover Markers (BTMs) in Children and Adolescents: A Proposal for Effective Use.儿童和青少年骨转换标志物(BTMs)的参考区间(RIs):有效应用建议
Biomedicines. 2024 Dec 27;13(1):34. doi: 10.3390/biomedicines13010034.
6
Height development and multiple bone health indicators in children aged 2-12 years with Duchenne muscular dystrophy (DMD).2至12岁杜氏肌营养不良症(DMD)患儿的身高发育及多项骨骼健康指标
PLoS One. 2025 Jan 10;20(1):e0316938. doi: 10.1371/journal.pone.0316938. eCollection 2025.
7
Serum bone turnover markers were associated with bone mass in late prepuberty and early puberty.血清骨转换标志物与青春发育后期和青春早期的骨量相关。
Acta Paediatr. 2025 May;114(5):944-953. doi: 10.1111/apa.17510. Epub 2024 Nov 21.
8
Bone turnover markers, and growth and bone parameters in infants participating in a vitamin D intervention study.参与维生素D干预研究的婴儿的骨转换标志物、生长及骨骼参数
Endocr Connect. 2024 Dec 20;14(1). doi: 10.1530/EC-24-0482. Print 2025 Jan 1.
9
Discordant responses of bone formation and absorption markers in Japanese infants with vitamin D deficiency: a comprehensive matched case-control study.日本维生素D缺乏婴儿骨形成和吸收标志物的不一致反应:一项全面的配对病例对照研究。
JBMR Plus. 2024 Mar 18;8(5):ziae033. doi: 10.1093/jbmrpl/ziae033. eCollection 2024 May.
10
Demographic and disease-related factors impact bone turnover and vitamin D in children with hemato-oncological diseases.人口统计学和疾病相关因素会影响血液肿瘤疾病患儿的骨转换和维生素D水平。
JBMR Plus. 2024 Feb 24;8(4):ziae017. doi: 10.1093/jbmrpl/ziae017. eCollection 2024 Apr.